Advertise here
Advertise here

Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK

Marissa Plescia , 2025-05-15 22:15:00 Medbridge, a digital care company, launched new AI-powered motion-capture capabilities on Thursday through its digital musculoskeletal and movement-based medicine platform. The Bellevue, Washington-based company works with clinicians, hospitals, and health systems to tackle musculoskeletal (MSK) issues. Its customers include Intermountain Health, Kaiser Permanente and AdventHealth. The company provides an AI-driven…

Read More

Can the brain be targeted to treat type 2 diabetes?

, 2025-05-15 21:22:00 Validation of AgRP neuron inactivation. Credit: Journal of Clinical Investigation (2025). DOI: 10.1172/JCI189842 Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of Clinical Investigation. For several years, researchers have known that…

Read More

New Data Back Crinecerfont in Congenital Adrenal Hyperplasia

, 2025-05-15 20:30:00 Orlando, Florida — New data add to the evidence supporting use of crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in both adults and children.  The latest findings from the company’s pediatric and adult phase 3 trials suggest that crinecerfont enables the dual goals of decreasing glucocorticoid…

Read More

Cognixion, Blackrock Neurotech partner on brain-computer interface technology

, 2025-05-15 19:47:00 Cognixion, a developer of noninvasive brain-computer interface (BCI) technology, announced that Blackrock Neurotech, a company that makes implantable BCIs, will provide Cognixion’s Axon-R wearable neural interface platform to research institutions via its distribution network. Blackrock Neurotech will act as an unrestricted distributor of Cognixion’s Axon-R, a noninvasive wearable that allows exact measurement and…

Read More

GOP Poised To Cut Billions in Health Benefits

, 2025-05-15 19:15:00 The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics…

Read More

Link between ADHD and obesity might depend on where you live

, 2025-05-15 18:44:00 A person with impulsivity / ADHD is struggling with physical exercise and binge eating while living in a city. Credit: Tian Gan, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) Attention-deficit/hyperactivity disorder (ADHD) might contribute to obesity by reducing physical activity—a relationship that can also be mediated by the features of the urban environment in which a…

Read More

No Barrett’s Survival Benefit With Regular Surveillance

, 2025-05-15 16:44:00 SAN DIEGO—Gastroenterologists have debated the best course of action for patients with Barrett’s esophagus for decades. Which is better for detecting early malignancy and preventing progression to esophageal adenocarcinoma (EAC) — surveillance endoscopy at regular intervals or only when symptoms occur? Does one offer a better chance of survival than the other?…

Read More

What and how you eat can increase levels of GLP-1 without drugs

, 2025-05-15 16:30:00 Credit: Pixabay/CC0 Public Domain Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects…

Read More

Study links all types of cyberbullying to PTSD in teens

, 2025-05-15 14:27:00 As concern grows over adolescent mental health, a new national study adds to the growing body of research showing that cyberbullying should be considered an adverse childhood experience (ACE) – a category of childhood trauma linked to long-term emotional, psychological and physical harm. While many assume that only extreme forms of online…

Read More

Telisotuzumab Vedotin Approved for NSCLC

, 2025-05-15 14:27:00 The US Food and Drug Administration (FDA) has granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis, AbbVie) for locally advanced or metastatic nonsquamous non–small cell lung cancer (NSCLC) with high c-Met protein overexpression after prior systemic therapy.  The FDA also approved the VENTANA MET (SP44) RxDx Assay (Roche Diagnostics) as a companion diagnostic…

Read More

AI Won’t Save Healthcare, But It Can Help Stop Wasting Millions

Holly Urban , 2025-05-15 13:55:00 When I was in business school in 2016, I wrote a composition on Blockchain and its implications in healthcare. At the time, all the experts proclaimed confidently that this new technology would “revolutionize” healthcare. I remember thinking at the time that I really didn’t get it. The systemic issues that exist in healthcare, with misaligned economic incentives driving system…

Read More

OpenAI unveils HealthBench to evaluate LLMs safety in healthcare

, 2025-05-15 15:14:00 OpenAI has announced the launch of HealthBench, a benchmark to evaluate AI models in healthcare using real-world applicability and physician judgment.  “The 5,000 conversations in HealthBench simulate interactions between AI models and individual users or clinicians. The task for a model is to provide the best possible response to the user’s last…

Read More

AI use in health care sparks questions about liability

Tara Bannow , 2025-05-15 14:07:00 Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. SAN FRANCISCO — Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues. Chief among them: a lack of consent from patients, whether any doctor checks the…

Read More

Multiple Naloxone Administrations Rise in EDs

, 2025-05-15 13:18:00 TOPLINE: The proportion of emergency department (ED) patients requiring multiple naloxone administrations increased from 10.1% in 2016 to 17.4% in 2022 in the MarketScan database and from 3.0% in 2016 to 7.3% in 2022 in the National Emergency Department Sample (NEDS) database, indicating an increasing trend. METHODOLOGY: Researchers conducted a retrospective claims-based…

Read More

Everything You Need to Know About Who Accredits Health Plans for Mental Health Parity Compliance

Luidgi Faubert , 2025-05-15 13:00:00 Mental health parity is an ethical imperative for health plans. Accreditation is an excellent way for health care leaders to ensure their organization meets parity standards. Discover who accredits health plans for mental health parity compliance and what the process entails. What Is Mental Health Parity? The Mental Health Parity…

Read More

Minister publishes ‘Sláintecare 2025+’ plan setting out Government priorities

Michael McHale , 2025-05-14 11:14:00 2024 progress report highlights reduction in trolley numbers but record ED presentations The Minister for Health has published an updated programme for the implementation of Slaintecare, highlighting 23 priorities in the areas of improving access, service quality and increasing capacity. ‘Path to Universal Healthcare: Sláintecare & Programme for Government 2025+’…

Read More

Will RFK Jr really Make America Healthy Again?

Simon Williams , 2025-05-15 10:06:00 Robert F Kennedy Jr’s confirmation as secretary of health and human services has arguably been President Trump’s most controversial appointment.1 But, beyond the catchy slogan, how do we know whether Kennedy will actually Make America Healthy Again (MAHA)? “Kennedy Jr is right that there is a chronic disease epidemic in…

Read More

Ajovy clinical trial shows little improvement over placebo in migraine and depression

, 2025-05-15 10:55:00 Credit: Marcus Aurelius from Pexels Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, report findings on the efficacy of fremanezumab (sold as Ajovy by Teva) in reducing migraine frequency and depressive symptoms among patients with comorbid major depressive disorder. Significant reductions in monthly migraine days and…

Read More

1 in 4 US Children Live With Addicted Parents

, 2025-05-15 10:40:00 TOPLINE: Nearly 19 million US children live with at least one parent meeting Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition; DSM-5) criteria for substance use disorder (SUD), representing one quarter of all US children in 2023. Over 6.1 million of these children have parents with comorbid SUD and mental illness,…

Read More

Professor Philip J. O’Halloran joins neurosurgery team at Blackrock Health Hermitage Clinic 

Editorial Staff , 2025-05-15 09:13:00 Leading expert in Neuro-Oncology and Sports-related Brain Injury joins Blackrock Health’s Hermitage Clinic Blackrock Health has announced the appointment of leading neurosurgeon Professor Philip J. O’Halloran at the Hermitage Clinic. The appointment reflects Blackrock Health’s ongoing commitment to offering cutting-edge care for patients with complex neurological conditions. Professor Philip O’Halloran….

Read More

How most-favored nation drug pricing could backfire

Darius Lakdawalla and Dana P. Goldman , 2025-05-15 08:30:00 The Trump administration faces a huge task under the president’s latest executive order: develop pricing targets in the next 30 days for thousands of drugs to equalize what Americans pay compared with patients overseas. They can accomplish his larger goal by embracing this opportunity to bring…

Read More

Lawrence Joseph Wilson | The BMJ

Benedict Flood, Simon Riddler , 2025-05-14 08:06:00 Benedict Flood, Simon Riddler Lawrence was born in Burnley and raised in Preston. He attended Newman College and completed arts A levels before a pre-med year and then a medical degree in Manchester, where he very much squeezed the pips out of his six years there. His journey…

Read More

Next generation module improves flow process automation

, 2025-05-15 03:54:00 Vapourtec has recently unveiled their Reaction Controller and Datalogger Module which improves the automation of flow chemistry experiments by enabling automated control and logging when using third-party pumps, recirculators, flow meters, sensors and balances. Image Credit: VAPOURTEC Ltd Designed for use in chemistry and chemical engineering, the module builds on the capabilities…

Read More
Advertise here
error: Content is protected !!